Lucid Diagnostics Inc (NAS:LUCD)
$ 0.748 0.009 (1.22%) Market Cap: 39.21 Mil Enterprise Value: 72.90 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 16/100

Q2 2022 Lucid Diagnostics Inc Earnings Call Transcript

Aug 15, 2022 / 08:30PM GMT
Release Date Price: $3.35 (-1.18%)
Operator

Greetings, and welcome to Lucid Diagnostics Second Quarter 2022 Business Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I'd now like to turn the conference over to your host, Adrian Miller. Please proceed, sir.

Adrian K. Miller
Lucid Diagnostics Inc. - VP of IR

Thank you, operator.

Good afternoon, everyone. This is Adrian Miller, Vice President of Investor Relations at Lucid Diagnostics. Thank you for participating in today's business update call. Joining me today on the call are Dr. Lishan Aklog, Chairman and CEO of Lucid Diagnostics, along with Dennis McGrath, the Chief Financial Officer of Lucid Diagnostics.

The press release announcing our business update and financial results is available on Lucid's website. Please take a moment to read the disclaimer about the forward-looking statements in the press release. The business update press release and this conference call, both include forward-looking statements, and these forward-looking statements are subject to known and unknown

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot